Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy

Study summary

This randomized pilot clinical trial studies the effects of meditation-based breathing training on patients' control of their breathing patterns and breathing-related movement, as well as on their psychological distress and treatment experience during radiation therapy. Meditation-based breathing training may decrease breathing-related movement and the amount of stress by improving breathing patterns in patients with abdominal or lung cancer undergoing radiation therapy.

Ask AI to explain this study

Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedEducational Intervention and Meditation Therapy

Plus 1 other study approaches.

Who it may be forAnxiety · Depression

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 18, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Albert Einstein College of Medicine

Study sponsor

Study overview

What this study is about

Purpose: Other
Study type: Interventional
Phase: Not applicable
Sponsor: Albert Einstein College of Medicine
Interventions being studied: Other: Educational Intervention; Other: Meditation Therapy; Other: Questionnaire Administration

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Radiation therapy→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

PHASE I - PATIENTS: All patients with abdominal tumors who have undergone at least 4 respiratory-gated radiotherapy treatments
PHASE I - PATIENTS: Full comprehension of English language
PHASE I - STAFF: All staff who have overseen the delivery of respiratory-gated radiotherapy for at least 6 months
PHASE I - STAFF: Full comprehension of English language
PHASE II: All patients with abdominal or lung tumors undergoing a respiratory gating simulation
PHASE II: Karnofsky performance status \> 60%
PHASE II: Life expectancy \> 3 months
PHASE II: No prior radiotherapy to the abdomen/lung
PHASE II: Full comprehension of English language

Reasons someone may not be able to joinExclusion criteria

PHASE I - PATIENTS: Inability to comprehend English language interview questions
PHASE I - STAFF: Inability to comprehend English language interview questions
PHASE II: Karnofsky performance status \< 60%
PHASE II: Prior radiotherapy to the abdomen/lung
PHASE II: Evidence of progressive or untreated gross disease outside of the abdomen/lung
PHASE II: Inability to comprehend English language breathing exercise instructions
PHASE II: Concurrent diagnosis of a significant respiratory disorder which requires the use of oxygen

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Albert Einstein College of MedicineThe Bronx, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 18, 2018. Always confirm current availability with the study team.

View original record ↗